Radionuclide Imaging Enhancement

Radionuclide imaging enhancement refers to strategies, molecules, or techniques designed to improve the quality, specificity, and sensitivity of medical images obtained using radionuclide-based modalities such as PET (positron emission tomography) and SPECT (single photon emission computed tomography). These enhancements typically involve the use of radiolabeled tracers or agents that target specific biological processes or molecular markers within tissues, thereby increasing the contrast between healthy and diseased tissue for more accurate diagnosis and monitoring. Key to enhancement is high specificity for molecular/cellular targets, rapid blood clearance, favorable pharmacokinetics, low toxicity and strong signal with minimal background noise.